Cooper Companies Inc (COO) FinancialsCOOCooper Companies Inc

The Cooper Companies, Inc. (COO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Toric and multifocal, accounting for 34.1% of total sales, equivalent to $363.80M. Other significant revenue streams include Sphere, other and Office and surgical procedures. Understanding this composition is critical for investors evaluating how COO navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, The Cooper Companies, Inc. maintains a gross margin of 62.36%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 20.82%, while the net margin is 40.59%. These profitability ratios, combined with a Return on Equity (ROE) of 6.84%, provide a clear picture of how effectively COO converts its operational activities into shareholder value.

In the context of the broader market, COO competes directly with industry leaders such as ALGN and AVTR. With a market capitalization of $14.86B, it holds a leading position in the sector. When comparing efficiency, COO's gross margin of 62.36% stands against ALGN's 72.82% and AVTR's 31.73%. Such benchmarking helps identify whether The Cooper Companies, Inc. is trading at a premium or discount relative to its financial performance.

Cooper Companies reported a total revenue of $1.066 billion in Q3 2026, with a gross margin of 62.36%. The net income for the same quarter was $432.8 million, showing a strong recovery from a loss in the previous quarter.